Company Performance Metrics
- Yongmin Cho: CTO
- Lee Shin-pyo: CSO
elegslab develops an AI-integrated preclinical testing platform and provides contract research services for pharmaceutical, biotech, and research organizations. The company focuses on high-throughput in vivo screening using C. elegans and microfluidic biochips to evaluate drug efficacy, toxicity, and safety. Its platform combines automated lab
hardware, biochips, and AI models to capture multi-feature behavioral and physiological data and generate standardized, large-scale datasets. elegslab offers non-clinical CRO services spanning study design, execution, data management, and reporting for applications in drugs, functional foods, and functional cosmetics. It also works on multi-omics, microbiome-related pipelines, and nano-formulation delivery complexes to enhance performance of cosmetic and food ingredients. Through these products and services, elegslab supports data-driven decision-making in early-stage development.